Delcath Systems

Delcath Systems, Inc. is an interventional oncology company dedicated to revolutionizing the treatment of patients with liver cancer. They focus on developing targeted, safe, and minimally-invasive therapies for patients with primary and metastatic liver cancers. Delcath's key product is HEPZATO KIT™, an FDA-approved treatment for adult patients with metastatic Uveal Melanoma, which delivers high-dose chemotherapy directly to the liver while minimizing systemic side effects.

The company is driven by a commitment to innovation and patient care, aiming to provide better clinical outcomes and improve quality of life for those facing serious liver cancer conditions. Delcath's team of experts is dedicated to advancing its technologies and procedures, fostering a future where liver cancer treatment is synonymous with precision, safety, and trust.

Delcath Systems offers some flexibility in its job postings, with the Medical Director position being listed as remote. However, there is no mention of flexible work arrangements like part-time hours or hybrid schedules, so it's unclear if these options are available for other roles.

Delcath Systems offers a comprehensive benefits package for its employees, including a comprehensive health plan, vision and dental insurance, a 401(k) savings plan with an employee stock purchase plan, and professional development opportunities. These benefits are designed to support the well-being and growth of employees and their families.

Delcath Systems, Inc. is a commercial-stage interventional oncology company dedicated to revolutionizing the treatment of liver cancer. Their mission is to develop and deliver groundbreaking therapies that improve clinical outcomes for patients while reducing drug-related side effects. They achieve this by utilizing drug management and delivery systems that focus on the specific needs of patients with primary and metastatic liver cancers.

Delcath Systems promotes a collaborative and results-oriented culture, fostering a passion for innovation and a commitment to improving patient outcomes. They value teamwork, accountability, compliance, market leadership, and customer focus, creating an environment where individuals can contribute their unique talents and make a significant impact. Their dedication to providing safe, effective, and minimally invasive therapies for liver cancer patients fuels their drive to excel in interventional oncology.

Delcath Systems, Inc. is committed to fostering an inclusive environment where all employees can thrive. They strive to recruit, develop, and retain talented individuals from a diverse candidate pool. The company proudly states they do not discriminate on the basis of race, gender, religion, age, sexual orientation, national origin, disability status, or any other characteristic protected by law. Their focus on diversity and inclusion is grounded in their company's core values and is deemed essential to their success.